Femasys Partners with CapexMD to Expand Patient Access to FemaSeed® Fertility Portfolio

Stock Information for Femasys Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Femasys Inc.

Femasys Advances OB/GYN Expansion with Adoption of FemaSeed® Fertility Portfolio by Minnesota Women's Care
Femasys Partners with UNC Health to Introduce Its FemaSeed® Fertility Portfolio Across Statewide OB/GYN Care Locations
Femasys Announces FDA Approval of Modular PMA Submission Approach for FemBloc®
Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update
Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Femasys Regains Compliance with Nasdaq Listing Requirements
Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG(TM) Catheter

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.